Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$126.27 - $191.71 $689,686 - $1.05 Million
-5,462 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$81.94 - $135.34 $447,556 - $739,227
5,462 New
5,462 $739,000
Q3 2020

Nov 12, 2020

SELL
$73.3 - $89.48 $218,434 - $266,650
-2,980 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$48.82 - $82.53 $145,483 - $245,939
2,980 New
2,980 $245,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.61B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.